US FDA Tags Theranos Sample Tubes As Uncleared Devices

The US FDA has stated that the Nanotainer blood specimen collection tubes made by embattled laboratory firm Theranos were being sold without proper 510(k) clearance and also cited the firm for a range of Quality System Regulation deficiencies in two FDA Form-483s posted online Oct. 27.

More from Archive

More from Medtech Insight